Well, hail to Dr. Paul Koch for his kind comments from Carribean Eye. Just to reiterate my new implementation of Fluramene in my diagnostic armamentarium for ocular surface disease has been a real time-saver. At the recent Winter Advanced Refractive Symposium in Park City, Utah, ocular surface disease management was a big topic especially in [...]
It is widely accepted that an abnormal, hyperosmolar tear film cannot successfully support the ocular surface ultimately leading to a loss of mucin-producing goblet cells and an increase in conjunctival and corneal surface desquamation. In general, the cell-to-cell junctions of the corneal epithelium are more resistant to the adverse effects of a dysfunional tear film [...]
